Hara, Y. et al. 2025. Clinical Utility of Targeted Next-Generation Sequencing for Determining Human Epidermal Growth Factor Receptor 2 Status and Optimizing Targeted Therapy in Breast Cancer. World Journal of Oncology. 16, 4 (Jul. 2025), 347–356. DOI:https://doi.org/10.14740/wjon2583.